Xilio Therapeutics Inc Revenue per Employee (XLO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Xilio Therapeutics Inc   (NASDAQ: XLO)
 

Xilio Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 131.22% in the second quarter 2026, year on year to cumulative value of $64 million, Xilio Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 843,316, this marks a new company high.
Within the Healthcare sector Employees of 121 other companies have achieved higher revenue per employee. While Xilio Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 1001 to 1207. Xilio Therapeutics Inc has 76 employees.


What is Sales per Employee Ratio?







XLO Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 131.22 % 331.67 % 693.85 % 742.51 % 242.98 %
Sales per Employee (TTM) $ 843,316 703,737 575,868 418,474 197,382
XLO's Total Ranking # 1207 # 1001 # 1280 # 1378 # 2278
Seq. Revenue Change 47.79 % -7.58 % -28.22 % 135.85 % 175.9 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 122
Overall Market # 1207

Revenue per Employee Statistics
High Average Low
$ 843,316 $ 476,800 $ 122,026
(Jun 30 2026)   (Mar 31 2025)



Financial Statements
Xilio Therapeutics Inc 's Revenue MRQ $ 19 Millions Visit XLO's Income Statement
Xilio Therapeutics Inc 's Revenues TTM $ 64 Millions Visit XLO's aggregate revenue growth
What are XLO's Sales? Visit XLO's Sales by Segment




Other Ratios
Xilio Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
XLO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for XLO's Competitors
Revenue per Employee for XLO's Suppliers
Revenue per Employee for XLO's Customers

You may also want to know
XLO's Sales Growth Rates XLO's Pe Price to earnings ratio XLO's Receivables Turnover Ratio XLO's Stock Quote
XLO's Net Income Growth Rates XLO's Ps Price to Sales ratio XLO's Sales per Employee XLO's Asset Turnover Ratio
XLO's Net Margin XLO's Pb Price to Book ratio XLO's Financial Strength Ratios XLO's Dividend Payout Ratio
Date modified: 2026-09-04T10:54:16+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 
Septerna Inc   760,630.77 $ 98.882  Million 130 
Dyadic International Inc   760,447.40 $ 3.802  Million
Transmedics Group Inc   744,396.44 $ 668.468  Million 898 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.